37
Views
4
CrossRef citations to date
0
Altmetric
Research Article

A Comparison of the Potency of Newly Developed Oximes (K074, K075) and Currently Available Oximes (Obidoxime, HI-6) to Counteract Soman-Induced Neurotoxicity in Rats

&
Pages 117-131 | Published online: 09 Oct 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jiri Kassa, Jana Zdarova Karasova & Sandra Tesarova. (2011) A comparison of the neuroprotective efficacy of individual oxime (HI-6) and combinations of oximes (HI-6+trimedoxime, HI-6+K203) in soman-poisoned rats. Drug and Chemical Toxicology 34:3, pages 233-239.
Read now
Miroslav Pohanka, Jana Zdarova Karasova, Kamil Musilek, Kamil Kuca, Young-Sik Jung & Jiri Kassa. (2011) Changes of rat plasma total low molecular weight antioxidant level after tabun exposure and consequent treatment by acetylcholinesterase reactivators. Journal of Enzyme Inhibition and Medicinal Chemistry 26:1, pages 93-97.
Read now

Articles from other publishers (2)

Christopher Pettineo, Robert Aitchison, Scott M Leikin, Stephen N Vogel & Jerrold B Leikin. (2009) Biological and Chemical Weapons of Mass Destruction: Updated Clinical Therapeutic Countermeasures Since 2003. American Journal of Therapeutics 16:1, pages 35-43.
Crossref
Jiri Kassa, Jana Karasova & Libor Vasina. (2007) The evaluation of neuroprotective efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI‐6) in cyclosarin‐poisoned rats. Journal of Applied Toxicology 27:6, pages 621-630.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.